Table 2.
Pattern of recurrence for different adjuvant therapies
| Distribution | S (n = 32) | S + CT (n = 23) | S + RT (n = 26) | S + CRT (n = 46) | Total (n = 127) |
|---|---|---|---|---|---|
| Recurrence | 27 (84.4%) | 20 (87.0%) | 15 (57.7%)* | 26 (56.5%)* | 88 (69.3%) |
| Lymph node | 22 (68.8%) | 19 (82.6%) | 13 (50.0%) | 19 (41.3%)* | 73 (57.5%) |
| Anastomosis | 2 (6.3%) | 2 (8.7%) | 1 (3.8%) | 2 (4.3%) | 7 (5.5%) |
| Haematology | 8 (25.0%) | 5 (21.7%) | 7 (26.9%) | 12 (26.1%) | 32 (25.2%) |
| Mixed | 5 (15.6%) | 5 (21.7%) # | 5 (19.2%) # | 7 (15.2%) | 22 (17.3%) |
| No recurrence | 5 (15.6%) | 3 (13.0%) | 11 (42.3%)* | 20 (43.5%)* | 39 (30.7%) |
#Recurrence was found in the lymph nodes, anastomosis, and haematologically at the same time. *The recurrence rate had a statistically significant difference compared to S (p < 0.05)